Research Labs

Share
and/or
22 Faculty Members found
Immunology Program
The Jayanta Chaudhuri Lab
Jayanta Chaudhuri, PhD
Immunologist Jayanta Chaudhuri studies the mechanisms of immunoglobulin gene diversification.
Chemical Biology Program
The Yael David Lab
Yael David, PhD
Yael David’s lab develops and applies methods in chemical biology toward studying epigenetic regulation and its correlation with disease states.
Cell Biology Program
The Hironori Funabiki Lab @ Rockefeller.edu
Hironori Funabiki, MD
Cell biologist Hironori Funabiki focuses on regulation of the structure and configuration of chromosomes during the cell division cycle.
Immunology Program
Michael Glickman Lab
Michael S. Glickman, MD
Physician-scientist Michael Glickman investigates the physiology and pathogenic mechanisms of mycobacteria, including the use of mycobacteria as bacterial cancer therapies.
Human Oncology & Pathogenesis Program
Tobias Hohl Lab Group
Tobias M. Hohl, MD, PhD
Physician-scientist Tobias Hohl studies the molecular pathogenesis of human fungal pathogens and how the immune system responds to them.
Molecular Biology Program
Prasad Jallepalli Lab Group
Prasad Jallepalli, MD, PhD
Molecular biologist Prasad Jallepalli studies the mechanisms that ensure accurate chromosome transmission in human cells.
Developmental Biology Program
Maria Jasin Lab Group
Maria Jasin, PhD
The Jasin laboratory focuses on double-strand break repair and genomic integrity in mammalian cells and the relationship to tumor suppression.
Molecular Biology Program
Scott Keeney Lab Group
Scott Keeney, PhD
Molecular biologist Scott Keeney investigates mechanisms of the initiation of meiotic recombination.
Molecular Biology Program
Thomas J. Kelly, MD, PhD
Molecular biologist Thomas Kelly studies regulatory mechanisms that control DNA replication during the cell cycle of eukaryotic cells.
Chemical Biology Program
The Minkui Luo Lab
Minkui Luo, PhD
Chemical Biologist Minkui Luo develops cutting-edge tools, technologies and concepts to annotate functions of protein-posttranslational modifications and designs inhibitors for cancer therapies.